Latest news
Samsung Bioepis lines up Opuviz syringe as European aflibercept rivals multiply - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 12:41:14 GMTSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar suits - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 00:42:00 GMTSamsung Bioepis battles Janssen, Pfizer, Novartis in global biosimilar fights - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 00:42:00 GMTTopic: Samsung Epis - koreatimes.co.krkoreatimes.co.kr · Mon, 03 Aug 2026 14:05:19 GMTPrice to book forward of Samsung Epis Holdings Co., Ltd. – KRX:0126Z0 - TradingViewTradingView · Sat, 01 Aug 2026 15:25:00 GMT